Advertisement
OtherInflammation, Immunopharmacology, and Asthma

Blockade of proteinase-activated receptor 2 (PAR 2) attenuates neuroinflammation in experimental autoimmune encephalomyelitis

Rahil Eftekhari, Benjamin W. Ewanchuk, Khalil S. Rawji, Robin M. Yates, Farshid Noorbakhsh, Hedwich F. Kuipers and Morley D. Hollenberg
Journal of Pharmacology and Experimental Therapeutics September 12, 2023, JPET-AR-2023-001685; DOI: https://doi.org/10.1124/jpet.123.001685
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherInflammation, Immunopharmacology, and Asthma

PAR2 inhibition reduces neuroinflammation

Rahil Eftekhari, Benjamin W. Ewanchuk, Khalil S. Rawji, Robin M. Yates, Farshid Noorbakhsh, Hedwich F. Kuipers and Morley D. Hollenberg
Journal of Pharmacology and Experimental Therapeutics September 12, 2023, JPET-AR-2023-001685; DOI: https://doi.org/10.1124/jpet.123.001685
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement